Home › Post-COVID Conditions (Long COVID) › Missouri
Post-COVID Conditions (Long COVID) clinical trials in Missouri
4 studies for Post-COVID Conditions (Long COVID) are looking for participants at sites in Missouri.
Cities in Missouri
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
- Saint Louis University Center for Vaccine Development, St Louis
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 64 · All sexes · Updated Oct 2, 2026 · NCT07536308Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Kansas City
- Research Site, St Louis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT05624450Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2
- Washington University in Saint Louis Department of Emergency Medicine, Emergency Care Research Core, St Louis
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 60 · All sexes · Updated Mar 12, 2026 · NCT06848309EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
- St. Louis Children's Hospital, St Louis
- Washington University School of Medicine, St Louis
RecruitingPhase 3
Ages 0 to 17 · All sexes · Updated Jul 17, 2025 · NCT05261139From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.